Delivery Order SPE2DB22D3301-SPE2DB25FY8DK
- Not listed
- The Defense Logistics Agency awarded a $2,268.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ceftriaxone 2 GM-D5W bags, with an ultimate completion date of August 4, 2025. This non-set-aside contract was awarded on August 1, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,054.62 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 2 GM-D5W bags, with an ultimate completion date of July 31, 2025. This award was made on a firm fixed price basis with no set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of Ceftriaxone 1 GM-D5W bags with a ceiling value of $3,436.68. This firm fixed-price delivery order, which is expected to be completed by August 6, 2025, represents a competitively awarded, non-set-aside contract and will be performed at the contractor's Conshohocken facility. Ceftriaxone...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,298.59 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 2 GM-D5W bags, an injectable antibiotic commonly used in military and federal healthcare settings. This competitively awarded, firm fixed-price delivery order was issued on August 1, 2025, with an ultimate completion date of August 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, a common antibiotic medication used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $2,890.58, represents a non-set-aside competitive award with an ultimate completion date of July 22, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $4,477.74 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 1 GM-D5W bags, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price delivery order was issued under no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Ceftriaxone is a third-generation cephalosporin antibiotic commonly used in military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ceftriaxone 1 GM-D5W bags valued at $1,234.64 under a firm fixed-price contract type. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, a firm fixed price delivery order contract valued at $3,815.58 to provide Ceftriaxone 2 GM-D5W bags. The delivery order has a completion date of February 26, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, serves as the prime contractor on this award, which does not have a set-aside designation. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,062.13 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 1 GM-D5W bags, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ceftriaxone is a broad-spectrum third-generation cephalosporin antibiotic commonly used across military and federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,025.88 firm fixed-price delivery order is for the supply of Ceftriaxone 1 GM-D5W bags, a critical antibiotic medication. The contract has an ultimate completion date of November 26, 2024 and was awarded on November 25, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY8DKDelivery Order
The Defense Logistics Agency awarded a $2,248.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle extending through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supplies to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company has demonstrated significant capacity to fulfill federal procurement requirements across multiple therapeutic domains through a diverse portfolio of delivery orders with the DLA Medical Supply Chain. Ceftriaxone is a third-generation cephalosporin antibiotic commonly used in military and veteran healthcare settings for treating serious bacterial infections, making this supply arrangement consistent with the company's extensive role in supporting Department of Defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 7/21/25 |